Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies – The Economic Times
0
Ranbaxy Laboratories Ltd has sued the U.S. Food and Drug Administration (FDA) for revoking approvals granted to the Indian firm to launch copies of two drugs including AstraZeneca Plc’s heartburn pill Nexium, court documents showed.
Read more – The Economic Times